Kidney Diseases
284
38
62
135
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
31 trials with published results (11%)
Research Maturity
135 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
19 terminated out of 284 trials
87.7%
+1.2% vs benchmark
16%
45 trials in Phase 3/4
23%
31 of 135 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 135 completed trials
Clinical Trials (284)
Savolitinib vs. Sunitinib in MET-driven PRCC.
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Dietary Intervention to Improve Kidney Transplant Outcomes
Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Methods for Nutrition, Inflammation, Kidney Function, Aging, Body Composition, and Hydration Among Older Patients
Urine and Ultrasound Screening for Kidney Disease in Children
A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
Archival of Human Biological Samples in CU-Med Biobank
Access to Kidney Transplantation in Minority Populations
Transformative Research in Diabetic Nephropathy 2.0
Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients
ID-ENTITY Trial- Evaluating Serial T-ID Monitoring
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi)
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>